Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®


Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer

A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial

Tatarian, Talar MD*; Jiang, Wei MD; Leiby, Benjamin E. PhD; Grigoli, Amanda BA*; Jimbo, Masaya MS*; Dabbish, Nooreen PhD; Neoptolemos, John P. MD§; Greenhalf, William PhD§; Costello, Eithne PhD§; Ghaneh, Paula MD§; Halloran, Christopher MD§; Palmer, Daniel PhD§; Buchler, Markus MD; Yeo, Charles J. MD*; Winter, Jordan M. MD*; Brody, Jonathan R. PhD*

Author Information
doi: 10.1097/SLA.0000000000002088
  • Buy


Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.